BODI vs GRPN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 17, 2026

BODI

50.3
AI Score
VS
BODI Wins

GRPN

37.2
AI Score

Investment Advisor Scores

BODI

50score
Recommendation
HOLD

GRPN

37score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BODI GRPN Winner
Revenue 103.90M 241.88M GRPN
Net Income 3.67M -14.62M BODI
Gross Margin 71.9% 90.7% GRPN
Net Margin 3.5% -6.0% BODI
Operating Income 4.78M -4.04M BODI
ROE 9.9% 20.3% GRPN
ROA 2.7% -2.4% BODI
Total Assets 136.51M 599.68M GRPN
Cash 32.39M 226.25M GRPN
Debt/Equity 0.67 -4.26 GRPN
Current Ratio 0.79 0.79 GRPN
Free Cash Flow -5.73M 1.50M GRPN

Relative Price Performance (Last 90 Days)

BODI 1M: -40.6% · 3M: -41.7% GRPN 1M: -22.9% · 3M: +7.5%

Current Technical Phase

BODI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.1%), weak momentum, RSI 32

RSI (14): 31.6 · Price: $6.37

GRPN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 31.2 · Price: $19.59

Fundamentals Snapshot

Metric BODI GRPN
Market Cap
Forward P/E 70.8 22.8
Trailing P/E 3.7
Revenue (TTM)
Revenue Growth -0.2% 0.0%
Gross Margin 0.7% 0.9%
Operating Margin 0.0% 0.0%
EPS 1.76 -3.13
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BODI is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.